GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Ebos Group Ltd (ASX:EBO) » Definitions » Median PS Value

Ebos Group (ASX:EBO) Median PS Value : A$26.17 (As of May. 24, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Ebos Group Median PS Value?

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Ebos Group's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was A$66.54. Ebos Group's 10-Year median PS Ratio is 0.3933. Therefore, the Median PS Value for today is A$26.17.

As of today (2024-05-24), Ebos Group's share price is A$32.55. Ebos Group's Median PS Value is A$26.17. Therefore, Ebos Group's Price to Median PS Value for today is 1.24.

The historical rank and industry rank for Ebos Group's Median PS Value or its related term are showing as below:

ASX:EBO' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.86   Med: 1.26   Max: 1.64
Current: 1.24

During the past 13 years, the highest Price to Median PS Value of Ebos Group was 1.64. The lowest was 0.86. And the median was 1.26.

ASX:EBO's Price-to-Median-PS-Value is ranked worse than
77.78% of 54 companies
in the Medical Distribution industry
Industry Median: 0.92 vs ASX:EBO: 1.24

Ebos Group Median PS Value Historical Data

The historical data trend for Ebos Group's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ebos Group Median PS Value Chart

Ebos Group Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Median PS Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.70 18.56 20.03 23.22 26.50

Ebos Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Median PS Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 23.22 - 26.50 -

Competitive Comparison of Ebos Group's Median PS Value

For the Medical Distribution subindustry, Ebos Group's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ebos Group's Price-to-Median-PS-Value Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Ebos Group's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where Ebos Group's Price-to-Median-PS-Value falls into.



Ebos Group Median PS Value Calculation

Ebos Group's Median PS Value for today is calculated as

Median PS Value=Revenue per Share (TTM)*10-Year Median PS Ratio
=66.54*0.3933
=26.17

10-Year Median PS Ratio is 0.3933.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Ebos Group's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was A$66.54.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ebos Group  (ASX:EBO) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

Ebos Group's Price to Median PS Value for today is calculated as

Price to Median PS Value=Share Price/Median PS Value
=32.55/26.17
=1.24

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ebos Group Median PS Value Related Terms

Thank you for viewing the detailed overview of Ebos Group's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Ebos Group (ASX:EBO) Business Description

Traded in Other Exchanges
Address
108 Wrights Road, P.O. Box 411, Christchurch, STL, NZL, 8024
Ebos is the largest pharmaceutical wholesaler and distributor across Australia and New Zealand. It services community pharmacies and hospitals, which contribute around 60% and 30% of revenue respectively. Drug pricing and wholesale margins for PBS medicine are governed by the Australian government's Pharmaceutical Benefits Scheme, or PBS. Wholesale gross margins are capped at 7% for community pharmacy and 10% for hospitals, and ongoing price reform typically results in low single digit revenue growth. Aside from pharma distribution, Ebos operates an animal health product wholesale, manufacturing and retail business, as well as undertaking third party logistics services. These segments are smaller contributors to group revenue but due to the unregulated nature are higher-margin operations.

Ebos Group (ASX:EBO) Headlines

No Headlines